Reporting the counterparty's growth as its own: management explains the company's coming year by narrating what its cust
The model's full reasoning — Q3 2022 call → NOThe question asks whether management explains the company's forward direction by narrating what its counterparties are themselves doing and scaling. I need to check if the transcript shows management describing specific customers' or partners' growth trajectories as the driver of the company's own coming volume. Looking at the transcript, management discusses: - Strong customer demand across most end markets - Record backlogs in Engineered Products - New business activity - Restructuring efforts - Pricing adjustments - Working capital investments The discussion of backlogs in Engineered Products mentions "customer demand for our equipment continues to be robust" and "New equipment bookings in the first nine months of the year totaled $175 million compared to $148 million a year ago" - but this is about the company's own bookings, not about what customers are doing. The Forged and Machine products business mentions "key end markets, including aerospace, rail and oil and gas continue to improve" - this is broad market conditions, not specific counterparties' trajectories. The Supply Technologies segment mentions "sales were strong across most of our end markets with the largest increases in semiconductor, power sports, heavy-duty truck and civilian aerospace" - again, broad end markets, not specific counterparties. There's no narration of specific customers' own ramps, launches, rollouts, capacity additions, or program build-outs. Management speaks about its own actions (pricing, restructuring, investments) and broad market conditions, but does not describe identifiable counterparties' own trajectories as the driver of the company's coming activity. The answer is NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| EMKR | EMCORE Corporation | Q4 2023 | 2023-12-12 | C+ |
| MBLY | Mobileye Global Inc. | Q2 2023 | 2023-07-28 | B+ |
| PI | Impinj, Inc. | Q4 2022 | 2023-02-08 | B+ |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| OOMA | Ooma, Inc. | Q3 2022 | 2021-12-02 | B+ |
| ILMN | Illumina, Inc. | Q1 2018 | 2018-04-24 | A |
| PLAB | Photronics, Inc. | Q2 2017 | 2017-05-17 | C+ |
| IONS | Ionis Pharmaceuticals, Inc. | Q1 2017 | 2017-05-09 | C |
| FNV | Franco-Nevada Corporation | Q3 2016 | 2016-11-08 | B+ |
| HXL | Hexcel Corporation | Q4 2015 | 2016-01-22 | B+ |
OOMA · Q3 2022 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's future volume as a consequence of those parties' trajectories.
MBLY · Q2 2023 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's volume as a consequence of those parties' trajectories.
ILMN · Q1 2018 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's future as a consequence of those parties' trajectories.